Regulatory Circuits that Link Cell Fate and Virulence in Histoplasma Capsulatum

Information

  • Research Project
  • 9204884
  • ApplicationId
    9204884
  • Core Project Number
    R00AI112691
  • Full Project Number
    4R00AI112691-02
  • Serial Number
    112691
  • FOA Number
    PA-11-197
  • Sub Project Id
  • Project Start Date
    7/1/2014 - 10 years ago
  • Project End Date
    2/28/2018 - 6 years ago
  • Program Officer Name
    DUNCAN, RORY A.
  • Budget Start Date
    3/2/2016 - 8 years ago
  • Budget End Date
    2/28/2017 - 7 years ago
  • Fiscal Year
    2016
  • Support Year
    02
  • Suffix
  • Award Notice Date
    3/2/2016 - 8 years ago

Regulatory Circuits that Link Cell Fate and Virulence in Histoplasma Capsulatum

DESCRIPTION (provided by applicant): Histoplasma capsulatum is one of several systemic dimorphic fungal pathogens that switch their growth program from an infectious mold form in the soil to a pathogenic yeast form in mammalian hosts. H. capsulatum causes up to 500,000 infections per year in the U.S. alone, making it the most common cause of fungal respiratory infections in healthy hosts. Infection occurs when the soil is disrupted, facilitating dispersion o hyphal fragments or spores that are inhaled by humans. The morphologic switch between the hyphal and yeast forms is critical to the establishment and maintenance of disease. Spores and hyphal fragments are the primary infectious agents; however, once introduced into the host, the pathogen converts to a budding-yeast form, which survives and replicates within host macrophages. In the laboratory, the switch between the infectious and parasitic states is modeled by changing the temperature: cells grow in the filamentous form at room temperature, whereas growth at 37?C is sufficient to trigger growth in the yeast form and expression of virulence factors. The long-term research goal of Dr. Beyhan-Pelvan is to understand how H. capsulatum cells sense host temperature and activate the expression of genes required for cell morphology and virulence. Despite its importance to human health, very little is known about how H. capsulatum senses and responds to human body temperature. Dr. Beyhan-Pelvan's prior research findings significantly contributed to the understanding of the molecular mechanism used by H. capsulatum to regulate cell morphology and virulence gene expression: she found that four transcriptional regulators, Ryp1,2,3,4, are the core components of a temperature-responsive intersecting regulatory network. In the mentored phase of this project, Dr. Beyhan-Pelvan aims to use findings from her previous work to identify and characterize novel virulence factors of H. capsulatum. Specifically, downstream targets of the Ryp proteins will be tested for their role in pathogenesis. These studies will also serve as a training opportunity for Dr. Beyhan-Pelvan to learn macrophage and mouse infection techniques. During the independent phase of this award, Dr. Beyhan-Pelvan aims to investigate factors that regulate Ryp proteins in response to host temperature. These studies will provide fundamental information on how cells sense temperature and turn on the appropriate virulence pathways in the host. Findings from this work can be used to investigate how other thermally dimorphic fungi can transition into a pathogenic form in response to host temperature. Ultimately, the information obtained from this project can be used to develop therapeutics for H. capsulatum infections and help prevent other dimorphic fungal infections. Dr. Beyhan-Pelvan has a longstanding interest in studying the molecular mechanisms used by microorganisms to sense and respond to environmental cues to regulate important biological processes (i.e. regulation of cell morphology, biofilm formation, motility or virulence). This project is proposed to complement her research interests and provide her with the required training in virulence studies. Dr. Sil's laboratory provides a unique opportunity to learn experimental techniques required to study both H. capsulatum's pathogenesis and physiology. Dr. Sil offers both funds and support staff to train Dr. Beyhan-Pelvan in macrophage and mouse infections with H. capsulatum. Additionally, as a mentor, Dr. Sil will work closely with Dr. Beyhan-Pelvan to prepare her for academic job searches. Furthermore, co-mentor Dr. Johnson and advisory committee members Drs. Engel, Madhani and Cox, who have facilitated transition of numerous post-doctoral trainees into independent investigators, will provide additional mentoring with emphasis on preparation for job searches and securing a tenure-track assistant professor position in a top-tier research university.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R00
  • Administering IC
    AI
  • Application Type
    4
  • Direct Cost Amount
    127692
  • Indirect Cost Amount
    121307
  • Total Cost
    248999
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:248999\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    NSS
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    J. CRAIG VENTER INSTITUTE, INC.
  • Organization Department
  • Organization DUNS
    076364392
  • Organization City
    ROCKVILLE
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    208503343
  • Organization District
    UNITED STATES